NON-VALVULAR ATRIAL FIBRILLATION
Clinical trials for NON-VALVULAR ATRIAL FIBRILLATION explained in plain language.
Never miss a new study
Get alerted when new NON-VALVULAR ATRIAL FIBRILLATION trials appear
Sign up with your email to follow new studies for NON-VALVULAR ATRIAL FIBRILLATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New heart device aims to cut stroke risk without blood thinners
Disease control TerminatedThis study tests a new device (Laminar) to close off a small pouch in the heart called the left atrial appendage in people with atrial fibrillation. The goal is to reduce the risk of stroke and blood clots. About 1500 participants will be randomly assigned to get either the new d…
Matched conditions: NON-VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 26, 2026 06:47 UTC
-
New device offers hope for AFib patients who Can't take blood thinners
Disease control OngoingThis study tests a new device that closes a small pouch in the heart (the left atrial appendage) in people with atrial fibrillation who cannot take blood thinners. The goal is to reduce the risk of stroke without needing lifelong medication. About 58 participants will be enrolled…
Matched conditions: NON-VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New heart plug could free AF patients from lifelong blood thinners
Disease control OngoingThis study tests a new device called the Conformal Left Atrial Appendage Seal in 64 people with non-valvular atrial fibrillation who are at high risk for stroke. The device is placed to close off a small pouch in the heart where blood clots often form, offering an alternative to …
Matched conditions: NON-VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Conformal Medical, Inc • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New heart device could cut stroke risk for millions unable to take blood thinners
Disease control OngoingThis study is testing a device called the Omega LAA Occluder, which is placed in the heart to close off a small pouch (the left atrial appendage) where blood clots can form in people with atrial fibrillation. The goal is to reduce the risk of stroke without needing long-term bloo…
Matched conditions: NON-VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Eclipse Medical Ltd. • Aim: Disease control
Last updated May 19, 2026 12:01 UTC